The headline writes itself as Dinglong Co., Ltd. posts a $149.5 million quarter—but behind the growth, critics say the story is rooted in the global surge of clone and counterfeit toner cartridges and aftermarket chips that continue to disrupt OEM dominance. As Canon, Brother, Epson, and HP invest heavily in patented cartridge designs, firmware, and authentication chips, industry watchdogs argue that a parallel ecosystem has emerged—one that reverse engineers these technologies, produces near-identical clone supplies, and floods global markets at sharply lower prices. Dinglong’s rapid revenue and profit gains, fueled by materials expansion and new subsidiaries, are being viewed by skeptics as part of this broader supply chain shift, where counterfeit toner and chip replication play a key role in undercutting OEM margins.
